Skip to content
Discover the latest music reviews, artist interviews, and i…

Individuals Discontinuing Weight-Loss Medications Put On Weight at a Quadrupled Rate Than Dieters

Image of medical syringe and scale
Weight management often requires ongoing approaches.

A recent study indicates that individuals who stop using popular GLP-1 drugs like Mounjaro or Wegovy tend to recover reduced body mass far faster than those who stop conventional diet and exercise regimens.

Findings released in a major health publication demonstrates that while obese people can lose a large proportion of their total mass while on the medication, the weight returns at an estimated rate of 0.8 kg per month upon discontinuation.

"Users buying these drugs should be cognizant of the danger of rapid rebound weight gain when the therapy is stopped," stated expert Dr. Susan Jebb.

Such speed of regain suggests a return to starting weight within about a year and a half.

Weighing Treatments

The analysis, which looked at 37 of studies involving over 9,000 of participants, compared the effects of these new drugs with older methods.

Researchers point out that individuals who shed pounds through lifestyle changes alone usually have a more gradual creep back—perhaps 0.1 kg a month—once they finish.

Understanding the Fast Regain

Experts propose the way of the drugs accounts for the accelerated rebound.

These medications copy a body's own chemical called GLP-1, which moderates feelings of fullness.

"Artificially providing GLP-1 concentrations several times higher than normal could lead to the system to produce less of its own natural hormone, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.

"Withdrawal of this medication results in hunger is no longer kept in check, making binge eating far more likely."

A Chronic Disease?

Medical guidelines recommend the injections for individuals with obesity-related health risks, alongside recommended lifestyle changes.

Professionals contend that, given the significant potential of relapse, the treatment is often ongoing.

This perspective is echoed by pharmaceutical companies, who note that the findings "emphasize the long-term nature of excess weight," similar to managing diseases like high blood pressure.

Patient Accounts

Individuals who have stopped the medication explain a intense return of hunger.

"I experienced a switch activating and you become starving," said one woman.

The struggle is exacerbated if users have not developed sustainable dietary or behavioural changes during therapy.

Significant Use

Figures show that millions of adults in the UK have tried these injections in the past year, with desire continuing to grow.

  • Adoption is more common among females than males.
  • The 40s and 50s age group shows the highest usage rates.
  • A large proportion obtain the drugs through private healthcare rather than public health services.

In conclusion, researchers caution that while these medications are powerful agents for weight loss, they are not a standalone solution and lasting health benefits hinges on combined lifestyle support.

JH
By

Jonathan Harrell

A music journalist with over a decade of experience covering the UK music scene, specializing in indie and alternative genres.

Sonic Palace

Type to search articles.